Table 1.
Characteristics of the Sample (N=202)
| Patient Characteristics: | Mean±SD or n (%) |
|---|---|
| Age (years) | 56.9±13.3 |
| Female | 101 (50.0) |
| Caucasian | 173 (85.6) |
| Body Mass Index (kg/m2) | 30.7±7.4 |
| Retired or on Disability due to Heart Failure | 92 (45.5) |
| Charlson Comorbidity Category: | |
| Score of 1 or 2 (low) | 124 (61.4) |
| Score of 3 or 4 (medium) | 66 (32.7) |
| Score of 5 or more (high) | 12 (5.9) |
| Heart Failure Characteristics: | |
| Left Ventricular Ejection Fraction (%) | 28.6±12.4 |
| NYHA Functional Class: | |
| Class II | 81 (40.1) |
| Class III | 113 (55.9) |
| Class IV | 8 (4.0) |
| Serum sodium (mEq/L) | 137.5±3.2 |
| Serum hematocrit (%) | 38.3±5.9 |
| Serum BUN-to-creatinine ratio (mg/dL:1) | 20.3±10.3 |
| Prescribed a β-blocker (%) | 183 (90.6) |
| Prescribed an ACE or ARB (%) | 162 (80.2) |
| Prescribed an aldosterone antagonist (%) | 86 (42.6) |
| Last Known Cardiac Index (L/min/m2) | 2.1±0.5 |
| Last Known PCWP (mm/Hg) | 18.9±8.8 |
| Symptoms: | |
| HFSPS Score | 24.3±16.0 |
| ESS Score | 8.2±4.9 |
| Significant Daytime Sleepiness | 69 (34.2) |
| PHQ9 Score | 6.9±5.8 |
| Moderate or Greater Depression | 53 (26.2) |
| BSI Anxiety Score | 0.52±0.59 |
| BSI Hostility Score | 0.41±0.53 |
| Event Risk Prediction: | |
| Seattle Heart Failure Score | 1.8±0.74 |
Abbreviations: ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker, BSI = Brief Symptom Inventory; BUN = blood urea nitrogen; ESS = Epworth Sleepiness Scale; HFSPS = Heart Failure Somatic Perception Scale; NYHA = New York Heart Association; PCWP = pulmonary capillary wedge pressure; PHQ9 = Patient Health Questionnaire 9 Items, SD = standard deviation.